HEMAB THERAPEUTICS HLDGS INC COM SHS
HEMAB THERAPEUTICS HLDGS INC COM SHS is a security (CUSIP 423494103) tracked across SEC portfolio filings. 4 institutional managers reported $3.3M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $15.2M via N-PORT as of 2026-05-31.
Summary
- Issuer: HEMAB THERAPEUTICS HLDGS INC
- Class: COM SHS
- CUSIP: 423494103
- Asset category: EC
- 13F holders: 4
- 13F value: $3.3M
- 13F period: 2026-06-30
- N-PORT fund positions: 2
- N-PORT value: $15.2M
- N-PORT report: 2026-05-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| Aberdeen Group plc | EDINBURGH, X0 | $1.9M | 52,117 |
| TD Asset Management Inc | Toronto, A6 | $1.2M | 33,098 |
| China Universal Asset Management Co., Ltd. | SHANGHAI, F4 | $132K | 3,600 |
| CITIGROUP INC | NEW YORK, NY | $77K | 2,095 |
Top fund holders (N-PORT)
More